ISSN: 2278-0238

International Journal of Research and Development in Pharmacy & Life Sciences
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Design, Synthesis And Antimicrobial Evaluation of 1,3,4-oxadiazole/1,2,4-triazole-Substituted Thiophenes

*Corresponding Author:

Copyright: © 2020  . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 
To read the full article Peer-reviewed Article PDF image

Abstract

The balloning level of antimicrobial resistance in pathogenic bacteria, together with the lack of new potential drug scaffolds in the pipeline, make the problem of infectious diseases a major public health concern. Thus, in this context, a novel series of 1,3,4-oxadiazole-substituted thiophenes (4a-m) and 1,2,4-triazole (6a-m) substituted thiophene derivatives were synthesized in order to develop new compounds with improved efficacy, and to overcome the problem of drug resistance. Characterization of all the synthesized derivatives was done by various spectroscopic techniques such as 1H NMR, 13C NMR and mass spectroscopy, and evaluated for antimicrobial activity against various pathological strains such as gram positive and gram negative bacteria. The results obtained from antimicrobial evaluation of synthesized compounds revealed that all the compounds displayed moderate to significant antimicrobial activity. In particular, compound 6e and 4e exhibited significant inhibitory potential with MIC ranging from 2-7 µg/ml against S. aureus, B. subtilis, P. aeruginosa and E. coli. Additionally, compound 6e was found to be highly potent against methicillin resistant S. aureus (MRSA; MIC = 2 µg/ml). Molecular docking studies were also performed to confer the possible mode of action and association studies indicate the binding of potent active compound with DHFR enzyme. Further, the mechanism of action has also been explored by atomic force microscopy (AFM), which reveals the bacterial cell wall deformity and cell wall rupturing that may lead to bacteria cell death. Additionally, in silico ADME prediction study suggested the drug like properties of active compounds.

Top